Publications

Export 4967 results:
Sort by: [ Author  (Asc)] Title Type Year
A B C [D] E F G H I J K L M N O P Q R S T U V W X Y Z   [Show ALL]
A
AbdelAzim, A. I., A. M. Ibrahim, and E. M. Aboul-Zahab, Development of an energy efficiency rating system for existing buildings using Analytic Hierarchy Process–The case of Egypt, , vol. 71: Pergamon, pp. 414 - 425, 2017. Abstract
n/a
Abdelaziz, O., and H. Attia, "Doppler ultrasonography in living donor liver transplantation recipients: Intra- and post-operative vascular complications", World Journal of Gastroenterology , vol. 22, issue 27, pp. 6145-6172, 2016.
AbdelAziz, O. A., and E. E. Khalil, "A Dry Passage To The Afterlife", Fluent News,, vol. 3, issue 1, pp. 28-29, 2006.
Abdelaziz, A. O., M. M. Nabil, A. H. Abdelmaksoud, and T. Elbaz, "De-novo versus recurrent hepatocellular carcinoma following direct-acting antiviral therapy for hepatitis C virus", European Journal of Gastroenterology and Hepatology, vol. 30, issue 1, pp. 39-43, 2018.
Abdelaziz, A. E., O. M. Hamed, and M. W. Ghafar, "Detection of Escherichia coli in frozen meat, liver, heart and kidney imported into Egypt", Research Journal of Pharmaceutical, Biological and Chemical Sciences, vol. 8, issue 2, pp. 1270-1278, 2017. detection_of_escherichia_coli_in_frozen_meat_liver_heart_and_kidney.pdf
Abdelaziz, A. O., M. M. Nabil, A. H. Abdelmaksoud, H. I. Shousha, A. A. Cordie, E. M. Hassan, D. A. Omran, R. Leithy, and T. M. Elbaz, "De-novo versus recurrent hepatocellular carcinoma following direct-acting antiviral therapy for hepatitis C virus.", European journal of gastroenterology & hepatology, vol. 30, issue 1, pp. 39-43, 2018 Jan. Abstract

INTRODUCTION: A recent appearance of direct-acting antivirals (DAAs) led to a surge in hepatitis C virus (HCV) management. Nowadays, a large proportion of treated patients have cirrhosis with a retained possibility to develop hepatocellular carcinoma (HCC) even after complete cure. We aimed to study tumoral differences between patients who developed HCC after DAAs as either a recurrence or de-novo HCC.

METHODS: We retrospectively analyzed 89 patients who presented to our HCC multidisciplinary clinic with HCC lesions following DAA therapy. A total of 45 patients had complete response to HCC according to the modified Response Evaluation Criteria in Solid Tumors before DAAs intake. Another 44 patients developed de-novo lesions after DAA treatment. Both groups were compared regarding their baseline characteristics, tumor criteria, response to DAAs as well response to HCC treatment.

RESULTS: Both groups showed no significant difference regarding their baseline characteristics (age, sex, Child-Pugh score, and performance status) or response to DAAs (P=0.5). No significant difference was present between groups according to number, site, and size of lesions. However, time elapsed between the end of DAAs therapy and first diagnosis of HCC was significantly longer in de-novo group (15.22±16.39 months) versus recurrence group (6.76±5.1 months) (P=0.008). In addition, response to ablation was significantly better in de-novo lesions compared with recurrent HCC (P=0.03).

CONCLUSIONS: Although de-novo HCC lesions significantly developed later than recurrent lesions in DAAs-treated patients, their response rates were significantly better. No differences were detected between both groups in their response to DAAs and their tumoral characteristics.

AbdelAziz, N. F., "Defying Newtonian Determinism in Tom Stoppard's Arcadia", Bulletin of the Faculty of Arts, Cairo University, 2010.
Abdelaziz, A. O., M. M. Nabil, A. H. Abdelmaksoud, H. I. Shousha, A. A. Cordie, E. M. Hassan, D. A. Omran, R. Leithy, and T. M. Elbaz, "De-novo versus recurrent hepatocellular carcinoma following direct-acting antiviral therapy for hepatitis C virus.", European journal of gastroenterology & hepatology, vol. 30, issue 1, pp. 39-43, 2018. Abstract

INTRODUCTION: A recent appearance of direct-acting antivirals (DAAs) led to a surge in hepatitis C virus (HCV) management. Nowadays, a large proportion of treated patients have cirrhosis with a retained possibility to develop hepatocellular carcinoma (HCC) even after complete cure. We aimed to study tumoral differences between patients who developed HCC after DAAs as either a recurrence or de-novo HCC.

METHODS: We retrospectively analyzed 89 patients who presented to our HCC multidisciplinary clinic with HCC lesions following DAA therapy. A total of 45 patients had complete response to HCC according to the modified Response Evaluation Criteria in Solid Tumors before DAAs intake. Another 44 patients developed de-novo lesions after DAA treatment. Both groups were compared regarding their baseline characteristics, tumor criteria, response to DAAs as well response to HCC treatment.

RESULTS: Both groups showed no significant difference regarding their baseline characteristics (age, sex, Child-Pugh score, and performance status) or response to DAAs (P=0.5). No significant difference was present between groups according to number, site, and size of lesions. However, time elapsed between the end of DAAs therapy and first diagnosis of HCC was significantly longer in de-novo group (15.22±16.39 months) versus recurrence group (6.76±5.1 months) (P=0.008). In addition, response to ablation was significantly better in de-novo lesions compared with recurrent HCC (P=0.03).

CONCLUSIONS: Although de-novo HCC lesions significantly developed later than recurrent lesions in DAAs-treated patients, their response rates were significantly better. No differences were detected between both groups in their response to DAAs and their tumoral characteristics.

Abdelaziz, A. O., M. M. Nabi, A. H. Abdelmaksoud, H. I. Shoushaa, A. A. Cordie, E. M. Hassan, D. A. Omran, R. Leithy, and T. M. Elbaz, "De-novo versus recurrent hepatocellular carcinoma following direct-acting antiviral therapy for hepatitis C virus", European Journal of Gastroenterology & Hepatology, vol. 30, issue 1, pp. 39–43, 2018.
Abdelaziz, T., J. Bahrani, and M. Thomas, "Diagnostic systems to warn of AKI", Hospital Healthcare Europe 2015. The Official HOPE reference book (the European Hospital and Healthcare Federation), LONDON, Cogora Limited, 2015.
Abdelaziz, A. O., M. M. Nabil, A. H. Abdelmaksoud, H. I. Shousha, A. A. Cordie, E. M. Hassan, D. A. Omran, R. Leithy, and T. M. Elbaz, "De-novo versus recurrent hepatocellular carcinoma following direct-acting antiviral therapy for hepatitis C virus.", European journal of gastroenterology & hepatology, vol. 30, issue 1, pp. 39-43, 2018 Jan. Abstract

INTRODUCTION: A recent appearance of direct-acting antivirals (DAAs) led to a surge in hepatitis C virus (HCV) management. Nowadays, a large proportion of treated patients have cirrhosis with a retained possibility to develop hepatocellular carcinoma (HCC) even after complete cure. We aimed to study tumoral differences between patients who developed HCC after DAAs as either a recurrence or de-novo HCC.

METHODS: We retrospectively analyzed 89 patients who presented to our HCC multidisciplinary clinic with HCC lesions following DAA therapy. A total of 45 patients had complete response to HCC according to the modified Response Evaluation Criteria in Solid Tumors before DAAs intake. Another 44 patients developed de-novo lesions after DAA treatment. Both groups were compared regarding their baseline characteristics, tumor criteria, response to DAAs as well response to HCC treatment.

RESULTS: Both groups showed no significant difference regarding their baseline characteristics (age, sex, Child-Pugh score, and performance status) or response to DAAs (P=0.5). No significant difference was present between groups according to number, site, and size of lesions. However, time elapsed between the end of DAAs therapy and first diagnosis of HCC was significantly longer in de-novo group (15.22±16.39 months) versus recurrence group (6.76±5.1 months) (P=0.008). In addition, response to ablation was significantly better in de-novo lesions compared with recurrent HCC (P=0.03).

CONCLUSIONS: Although de-novo HCC lesions significantly developed later than recurrent lesions in DAAs-treated patients, their response rates were significantly better. No differences were detected between both groups in their response to DAAs and their tumoral characteristics.

Abdelbaky, M. A., X. Liu, and D. Jiang, "Design and implementation of partial offline fuzzy model-predictive pitch controller for large-scale wind-turbines", Renewable Energy, vol. 145, pp. 981-996, 2020.
Abdelbarr, M. H., A. Massari, M. D. Kohler, and S. F. Masri, "Decomposition Approach for Damage Detection, Localization, and Quantification for a 52-Story Building in Downtown Los Angeles", Journal of Engineering Mechanics, vol. 146, no. 9, pp. 04020089, 2020. Abstract

Among the most challenging problems in the field of damage detection and condition assessment in large structures is the ability to reliably detect, locate, and quantify relatively small changes in their dynamic response, based on vibration signal analysis. In this study, a substructuring approach, which uses a nonparametric identification method, was applied to simulated damage data from a high-fidelity and validated three-dimensional (3D) finite element model of a 52-story high-rise office building, located in downtown Los Angeles. Results of this study indicate that the approach not only yields identification results that match well-known global (linear) system identification methods, such as NExT/ERA, but it also provides additional benefits that global identification approaches suffer from. These benefits include: (1) enhanced sensitivity to small structural parameter changes, (2) ability to provide location information about the region in the large structure in which damage has occurred, and (3) not assuming that the underlying structure is linear. Thus, the approach is capable of detecting, quantifying, and classifying changes, when they do occur, if the actual building is subjected to strong earthquake ground motion.

Abdelbary, A. A., I. Elsayed, and A. H. Elshafeey, "Design and development of novel lipid based gastroretentive delivery system: response surface analysis, in-vivo imaging and pharmacokinetic study.", Drug delivery, vol. 22, issue 1, pp. 37-49, 2015 Jan. Abstract

Famotidine HCl has low bioavailability (40-45%) due to its narrow absorption window and low solubility in intestinal pH. Lipids were utilized in the formulation of novel gastroretentive dosage forms to increase the availability of famotidine HCl at its absorption site. Novel non-swellable gastroretentive lipid disks (D) and swellable compression coated tablets with a lipid core (T) were prepared. Formulae were characterized by friability testing, in-vitro buoyancy, in-vitro drug release and scanning electron microscopy (SEM). Factorial designs of 2(2 )× 3(1) and 3(2) were planned for the optimization of disks and tablets, respectively, using Design-Expert® software. X-ray imaging was used for the in-vivo visualization of the selected formula in human gastrointestinal tract (GIT). Moreover, a bioavailability study was performed in healthy human volunteers using the optimized disk formula (D10). Results showed that formulae D10 (containing stearyl alcohol and polyethylene glycol in a ratio of 9:1 w/w) and T7 (containing polyethylene oxide only) had highest desirability values (0.684 and 0.842, respectively). Lipids achieved instantaneous floating and sustained the release of famotidine HCl over a prolonged period of time with significant bioavailability enhancement.

Abdelbary, A. A. a, I. a Elsayed, and A. H. a b Elshafeey, "Design and development of novel lipid based gastroretentive delivery system: Response surface analysis, in-vivo imaging and pharmacokinetic study", Drug Delivery, vol. 22, no. 1, pp. 37-49, 2015. AbstractWebsite

Famotidine HCl has low bioavailability (40-45%) due to its narrow absorption window and low solubility in intestinal pH. Lipids were utilized in the formulation of novel gastroretentive dosage forms to increase the availability of famotidine HCl at its absorption site. Novel non-swellable gastroretentive lipid disks (D) and swellable compression coated tablets with a lipid core (T) were prepared. Formulae were characterized by friability testing, in-vitro buoyancy, in-vitro drug release and scanning electron microscopy (SEM). Factorial designs of 22× 31 and 32 were planned for the optimization of disks and tablets, respectively, using Design-Expert® software. X-ray imaging was used for the in-vivo visualization of the selected formula in human gastrointestinal tract (GIT). Moreover, a bioavailability study was performed in healthy human volunteers using the optimized disk formula (D10). Results showed that formulae D10 (containing stearyl alcohol and polyethylene glycol in a ratio of 9:1 w/w) and T7 (containing polyethylene oxide only) had highest desirability values (0.684 and 0.842, respectively). Lipids achieved instantaneous floating and sustained the release of famotidine HCl over a prolonged period of time with significant bioavailability enhancement.

Abdelbary, G. A., and R. H. Fahmy, "Diazepam-Loaded Solid Lipid Nanoparticles: Design and Characterization. ", AAPS PharmSciTech, vol. 10, issue 1, pp. 211-219, 2009.
Abdelbary, A. A., I. Elsayed, and A. H. Elshafeey, "Design and development of novel lipid based gastroretentive delivery system: response surface analysis, in-vivo imaging and pharmacokinetic study. ", Drug Delivery, vol. 22, issue 1, pp. 37-49, 2015.
AbdelFadeel, K. Q., K. Elsayed, A. Khattab, and F. Digham, "Dynamic Spectrum Access for Primary Operators Exploiting LTE-A Carrier Aggregation", IEEE ICNC, Anaheim, CA, 2015.
AbdelFadeel, K. Q., K. Elsayed, A. Khattab, and F. Digham, "Dynamic Spectrum Access for Primary Operators Via Carrier Aggregation in LTE-Advanced Environments", IEEE ICNC , Feb. 2015. Abstract

n/a

Abdelfattah, M., A. A.El-Kholy, M. G. Al-Inany, I. K. Beheiry, and D. Saleh, "Device associated infections in adult intensive care units in public versus private hospitals in Egypt", 2nd International Conference on Prevention and Infection Control (ICPIC 2013), Geneva, Switzerland, 25-28 June 2013. art3a10.11862f2047-2994-2-s1-p16.pdf
Abdelgawad, H., T. Abdulazim, B. Abdulhai, A. Hadayeghi, and W. Harrett, "Data imputation and nested seasonality time series modelling for permanent data collection stations: methodology and application to Ontario", Canadian Journal of Civil Engineering, vol. 42, no. 5: NRC Research Press, pp. 287–302, 2015. Abstract
n/a
Tourism